A Beta-only IL-2 ImmunoTherapY Study

Name: A Beta-only IL-2 ImmunoTherapY Study
License: Public Domain

Medicenna Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple-negative-breast-cancer

advanced solid tumor, unresectable solid tumor, clear cell renal cell carcinoma, triple negative breast cancer, non-small cell lung cancer squamous, non-small cell lung cancer non-squamous

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 245502
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.